Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Kindstar Global Partners with Biostate AI to Advance Precision Medicine
CompanyDeals

Kindstar Global Partners with Biostate AI to Advance Precision Medicine

June 9, 2025
Genesis MedTech Wins NMPA Approval for Locally Developed Thrombus Aspiration Catheter
CompanyMedical Device

Genesis MedTech Wins NMPA Approval for Locally Developed Thrombus Aspiration Catheter

June 9, 2025
Zelgen Bio Collaborates with Merck KGaA for rhTSH Promotion in China
CompanyDeals

Zelgen Bio Collaborates with Merck KGaA for rhTSH Promotion in China

June 6, 2025
HELP Therapeutics' iPSC-Derived Cardiomyocyte Therapy Enters US Clinical Trials
CompanyDrug

HELP Therapeutics’ iPSC-Derived Cardiomyocyte Therapy Enters US Clinical Trials

June 6, 2025
Lancet Robotics Secures Series A+ Funding for Surgical Robot Development
CompanyDeals

Lancet Robotics Secures Series A+ Funding for Surgical Robot Development

June 6, 2025
Biocytogen's RenMab Platform Wins Japanese Patent, Expanding IP Portfolio
Legal / IP

Biocytogen’s RenMab Platform Wins Japanese Patent, Expanding IP Portfolio

June 6, 2025
Bayer's Vividion Gains Global Rights to WRN Inhibitor VVD-214
CompanyDeals

Bayer’s Vividion Gains Global Rights to WRN Inhibitor VVD-214

June 6, 2025
Nanjing Leads Biolabs Files for Hong Kong IPO Amid Product Pipeline Progress
CompanyDeals

Nanjing Leads Biolabs Files for Hong Kong IPO Amid Product Pipeline Progress

June 6, 2025
Acotec Scientific Gains NMPA Approval for AcoArt Verbena Vertebral Balloon
CompanyMedical Device

Acotec Scientific Gains NMPA Approval for AcoArt Verbena Vertebral Balloon

June 6, 2025
Hengrui Pharmaceuticals Gains NMPA Approval for Phase Ib/II Study of SHR-A1811, Adebrelimab and Famitinib in Solid Tumors
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for Phase Ib/II Study of SHR-A1811, Adebrelimab and Famitinib in Solid Tumors

June 6, 2025
Qure Biotechnology Secures RMB 100 Million Series C1 Financing
CompanyDeals

Qure Biotechnology Secures RMB 100 Million Series C1 Financing

June 6, 2025
Lianhuan Pharma Gains NMPA Approval for No-Spa Generic
CompanyDrug

Lianhuan Pharma Gains NMPA Approval for No-Spa Generic

June 6, 2025
1 2 … 141 142 143 144 145 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up